Schoemaker, Nadja E <br/><br/>
Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study.  [electronic resource] 

 -  Anti-cancer drugs  Jan 2002 
 - 87-91 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200201000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers--blood<br/>Cisplatin--administration & dosage<br/>DNA Topoisomerases, Type I--metabolism<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Leukocytes--enzymology<br/>Middle Aged<br/>Ovarian Neoplasms--blood<br/>Paclitaxel--administration & dosage<br/>Topotecan--administration & dosage<br/>Tumor Cells, Cultured--drug effects